These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3163105)

  • 21. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
    Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
    Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors.
    Nitta N; Ohta S; Tanaka T; Takazakura R; Toyama T; Sonoda A; Seko A; Furukawa A; Takahashi M; Murata K; Kurumi Y; Tani T; Sakamoto T; Tabata Y
    Eur J Radiol; 2009 Sep; 71(3):519-26. PubMed ID: 18617345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
    Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
    Kelsen D; Ginsberg R; Bains M; Cooper J; Arquette M; Forastiere AA; Ilson D
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-77-S19-81. PubMed ID: 9427272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
    Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
    Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with aclarubicin in metastatic breast cancer.
    Simader H; Hausmaninger H; Fereberger W; Samonigg H
    Eur J Haematol Suppl; 1987; 47():71-6. PubMed ID: 3471528
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination effects of CDDP, ACR and HCFU on progressive urothelial tumors].
    Ueda K; Jinno H; Watanabe H; Ohtaguro K
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1318-22. PubMed ID: 3859251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of aclacinomycin A for the intraperitoneal treatment of human ovarian carcinoma.
    Louie KG; Hamilton TC; Behrens BC; Grotzinger KR; McKoy WM; Myers CE; Young RC; Ozols RF
    Cancer Chemother Pharmacol; 1986; 18(2):153-6. PubMed ID: 3466726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aclarubicin in advanced thyroid cancer: a phase II study.
    Samonigg H; Hossfeld DK; Spehn J; Fill H; Leb G
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1271-5. PubMed ID: 3181249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats].
    Geodakian SV; Firsov AA; Fomina IP
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic study of aclarubicin. The distribution of the preparation and its biologically active metabolites in rat tissues].
    Firsov AA; Geodakian SV; Egorov LV; Terent'eva TG
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):773-7. PubMed ID: 3480700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal effect of aclacinomycin A on cultured mouse L cells.
    Tanabe M; Miyamoto T; Nakajima Y; Terasima T
    Gan; 1980 Oct; 71(5):699-703. PubMed ID: 6939647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.